{"id":372740,"title":"Quality Overall Summary – Biologic Products (QOS-B) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T17:41:56.097000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/preparation-quality-information-drug-submissions-ctd-format-biotherapeutic-blood-products/quality-overall-summary-biologic-products.html","snippet":"Quality Overall Summary – Biologic Products (QOS-B) Foreword The Quality Overall Summary (QOS) (Module 2.3) follows the scope and the outline of the Quality Body of Data (Module 3.2). This QOS-B template can be used by sponsors to summarize the Quality information for all types…","rawSnapshotUrl":"/api/snapshots/raw/372740","browseUrl":"https://replay.healtharchive.ca/job-6/20260411174156/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/preparation-quality-information-drug-submissions-ctd-format-biotherapeutic-blood-products/quality-overall-summary-biologic-products.html#ha_snapshot=372740","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}